Return of fertility in nulliparous and parous women after levonorgestrel 52 mg intrauterine system discontinuation

Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system.

OBJECTIVE To assess 3-year data on the efficacy and safety of a new 52-mg levonorgestrel intrauterine contraceptive (LNG20) designed for up to 7 years use. STUDY DESIGN Nulliparous and parous women aged 16-45 years at enrollment with regular menstrual cycles and requesting contraception were enrolled in an open-label, partially randomized trial to evaluate LNG20. The primary outcome was pregn...

Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A☆☆☆

OBJECTIVES To compare rates of unintended pregnancy, method continuation and reasons for removal among women using the 52-mg levonorgestrel (daily release 20 microg) levonorgestrel IUD (LNG-IUD) or the copper T 380A (TCu380A) intrauterine device. STUDY DESIGN This was an open-label 7-year randomized controlled trial in 20 centres, 11 of which in China. Data on 1884 women with interval inserti...

Bleeding patterns do not differ between obese and non-obese women using a levonorgestrel 52-mg intrauterine system

New intrauterine technologies for contraception and treatment in nulliparous/adolescent and parous women

The IUD (intra uterine device) is a highly effective method of contraception that is underused. New developments in intrauterine technology, smaller frameless copper and levonorgestrel-releasing devices, could help increase the prevalence-- of use in adolescents and nulliparous women. Because adolescents and young nulliparous women contribute disproportionately to the epidemic of unintended pre...

The return of fertility after discontinuation of oral contraception in Malaysian women.

The return of fertility after discontinuation of oral contraception was studied in a cross-sectional survey of 61 patients who were desirous of a further pregnancy. For controls, 380 women who did not take any oral contraception were used. Cumulative conception rates in the pill users were reduced but not significantly during the first three (p = 0.15) and six months (p = 0.20). By 12 months th...